Healthcare ETF Defies Market Slump as Key Holding Surges 15% on Major AI Drug Discovery Alliance

Stock News

昨天

ChinaAMC Hang Seng Biotech ETF (03069) climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.

GenScript Biotech (01548), one of the top ten holdings in the ChinaAMC Hang Seng Biotech ETF, skyrocketed 15% today following its announcement of a collaboration with Eli Lilly's AI/machine learning drug discovery platform, Lilly TuneLab. Additionally, Novo Nordisk and Anthropic have signed a cooperation agreement, together fueling gains across the AI-driven pharmaceutical supply chain.

Where to begin with this momentum? Public filings show the ChinaAMC Hang Seng Biotech ETF tracks the Hang Seng Biotechnology Index, with constituent stocks including GenScript Biotech, Innovent Biologics, and BeiGene—a roster of leading China-based biotech firms with global competitiveness. The ETF was officially included in the Stock Connect program on July 22, 2024, making it one of the accessible Hong Kong-listed ETFs for mainland investors seeking exposure to innovative drugs and biotech through the channel.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1178899864"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1178899864\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1178899864?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 10:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178899864","market":"fut","top_or_hot":-1,"title":"Healthcare ETF Defies Market Slump as Key Holding Surges 15% on Major AI Drug Discovery Alliance","media":"Stock News","content":"<p><b>ChinaAMC Hang Seng Biotech ETF (03069)</b> climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.<br><br><b>GenScript Biotech (01548)</b>, one of the top ten holdings in the ChinaAMC Hang Seng Biotech ETF, skyrocketed 15% today following its announcement of a collaboration with <b>Eli Lilly's</b> AI/machine learning drug discovery platform, Lilly TuneLab. Additionally, <b>Novo Nordisk</b> and <b>Anthropic</b> have signed a cooperation agreement, together fueling gains across the AI-driven pharmaceutical supply chain.<br><br>Where to begin with this momentum? Public filings show the ChinaAMC Hang Seng Biotech ETF tracks the Hang Seng Biotechnology Index, with constituent stocks including <b>GenScript Biotech</b>, <b>Innovent Biologics</b>, and <b>BeiGene</b>—a roster of leading China-based biotech firms with global competitiveness. The ETF was officially included in the Stock Connect program on July 22, 2024, making it one of the accessible Hong Kong-listed ETFs for mainland investors seeking exposure to innovative drugs and biotech through the channel.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healthcare ETF Defies Market Slump as Key Holding Surges 15% on Major AI Drug Discovery Alliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthcare ETF Defies Market Slump as Key Holding Surges 15% on Major AI Drug Discovery Alliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-17 10:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>ChinaAMC Hang Seng Biotech ETF (03069)</b> climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.<br><br><b>GenScript Biotech (01548)</b>, one of the top ten holdings in the ChinaAMC Hang Seng Biotech ETF, skyrocketed 15% today following its announcement of a collaboration with <b>Eli Lilly's</b> AI/machine learning drug discovery platform, Lilly TuneLab. Additionally, <b>Novo Nordisk</b> and <b>Anthropic</b> have signed a cooperation agreement, together fueling gains across the AI-driven pharmaceutical supply chain.<br><br>Where to begin with this momentum? Public filings show the ChinaAMC Hang Seng Biotech ETF tracks the Hang Seng Biotechnology Index, with constituent stocks including <b>GenScript Biotech</b>, <b>Innovent Biologics</b>, and <b>BeiGene</b>—a roster of leading China-based biotech firms with global competitiveness. The ETF was officially included in the Stock Connect program on July 22, 2024, making it one of the accessible Hong Kong-listed ETFs for mainland investors seeking exposure to innovative drugs and biotech through the channel.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01477","symbol_name":"欧康维视生物-B","start_time":0,"source_url":"","article_id":"1178899864","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178899864","pubTimestamp":1789611607,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"ChinaAMC Hang Seng Biotech ETF (03069) climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.GenScript...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01477":"欧康维视生物-B","BK1191":"制药","ARTY":"ISHARES FUTURE AI & TECH ETF","AIPO":"Defiance AI and Power Infrastructure ETF","FDN":"First Trust Dow Jones Internet I","03069":"华夏恒生生科","BK4550":"红杉资本持仓","BK4588":"碎股","AGIX":"通用人工智能 ETF-AGIX","BK4585":"ETF&股票定投概念","BK1574":"生物医药B类股","VTHR":"Vanguard Russell 3000 ETF","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","QTOC":"Innovator Growth Accelerated Plus ETF - October"},"translate_title":"主要人工智能药物发现联盟的关键持股激增 15%，医疗保健 ETF 克服市场低迷","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHAT":1,"QTOC":1,"FDN":1,"AGIX":1,"01477":1,"ARTY":1,"03069":1,"AIPO":1,"VTHR":1},"content_text":"ChinaAMC Hang Seng Biotech ETF (03069) climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.GenScript Biotech (01548), one of the top ten holdings in the ChinaAMC Hang Seng Biotech ETF, skyrocketed 15% today following its announcement of a collaboration with Eli Lilly's AI/machine learning drug discovery platform, Lilly TuneLab. Additionally, Novo Nordisk and Anthropic have signed a cooperation agreement, together fueling gains across the AI-driven pharmaceutical supply chain.Where to begin with this momentum? Public filings show the ChinaAMC Hang Seng Biotech ETF tracks the Hang Seng Biotechnology Index, with constituent stocks including GenScript Biotech, Innovent Biologics, and BeiGene—a roster of leading China-based biotech firms with global competitiveness. The ETF was officially included in the Stock Connect program on July 22, 2024, making it one of the accessible Hong Kong-listed ETFs for mainland investors seeking exposure to innovative drugs and biotech through the channel.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}